Finance

Lists
1AE:ETR
argenx SE
€ ७३०.४०
०.००%
(०.००) 1D
अक्टोबर ९, १७:३५:४६ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1AE...
Mkt. cap
४५.८४ अरब
Avg. vol.
७८.००
Volume
०.००
P/E ratio
३१.०८
52-wk high
€ ९२२.००
52-wk low
€ ५७४.२०
EPS
€ २३.५०
No. of employees
२ हजार
Mkt. cap
४५.८४ अरब
Avg. vol.
७८.००
Volume
०.००
P/E ratio
३१.०८
52-wk high
€ ९२२.००
52-wk low
€ ५७४.२०
EPS
€ २३.५०
No. of employees
२ हजार
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
१ घण्टा पहिले
argenx stock pre-market at EUR 734.10
AD HOC NEWS
AD HOC NEWS
·
३ दिन पहिले
Argenx stock pre-market: EUR 729.20, prior close EUR 729.90
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE
CEO-
Employees१.८६ हजार
Founded२००८ अप्रिल २५
Headquarters-
Sector-
Websiteargenx.com
Next call १० दिनमा
अक्टोबर २२, बिहि, ०९:००
Fiscal period
Q3 2026
- / -US$ ९.७८
Revenue / Est. (USD)
- / १.६४ अरब
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.१५ अरब
१.३१ अरब
१.३१ अरब
१.५४ अरब
Cost of goods sold
४६.५१ करोड
५२.१४ करोड
५६.४० करोड
६३.१० करोड
Cost of revenue
४६.५१ करोड
५२.१४ करोड
५६.४० करोड
६३.१० करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३३.६३ करोड
४२.९६ करोड
३५.५० करोड
४१.७० करोड
Operating expense
३३.६३ करोड
४२.९६ करोड
३५.५० करोड
४१.७० करोड
Total operating expenses
८०.१४ करोड
९५.१० करोड
९१.९० करोड
१.०५ अरब
Operating income
३५.०० करोड
३५.९६ करोड
३९.४० करोड
४९.३० करोड
Other non operating income
-
-९.०७ लाख
-
-१०.०० लाख
EBT including unusual items
३८.६१ करोड
४०.३३ करोड
४२.६० करोड
५३.१० करोड
EBT excluding unusual items
३८.६१ करोड
३९.१७ करोड
४२.६० करोड
५३.१० करोड
Income tax expense
४.१८ करोड
-१२.९७ करोड
६.०० करोड
५.९० करोड
Effective tax rate
१०.८३%
-३२.१५%
१४.०८%
११.११%
Other operating expenses
-
-
-
-
Net income
३४.४३ करोड
५३.३० करोड
३६.६० करोड
४७.२० करोड
Net profit margin
२९.९०%
४०.६७%
२७.८८%
३०.६३%
Earnings per share
५.१८
८.०२
५.५२
७.३२
Interest and investment income
४.२७ करोड
४.५० करोड
४.४० करोड
४.८० करोड
Interest expense
-९.९३ लाख
-
-१०.०० लाख
-१०.०० लाख
Net interest expenses
४.१७ करोड
४.५० करोड
४.३० करोड
४.७० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
३५.०४ करोड
३६.१४ करोड
३९.५८ करोड
५०.१५ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू